PlainRecalls
FDA Drug Low Class III Terminated

Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.

Reported: February 15, 2017 Initiated: December 19, 2016 #D-0471-2017

Product Description

Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.

Reason for Recall

Superpotent Drug: Product may not meet specifications throughout shelf life.

Details

Recalling Firm
Apotex Inc.
Units Affected
67,946 bottles
Distribution
Nationwide in the USA
Location
Toronto, N/A

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.. Recalled by Apotex Inc.. Units affected: 67,946 bottles.
Why was this product recalled?
Superpotent Drug: Product may not meet specifications throughout shelf life.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 15, 2017. Severity: Low. Recall number: D-0471-2017.